4.6 Review

Lupus Nephritis: Current Perspectives and Moving Forward

Journal

JOURNAL OF INFLAMMATION RESEARCH
Volume 15, Issue -, Pages 6533-6552

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/JIR.S363722

Keywords

systemic lupus erythematosus; glomerulonephritis; proteinuria; autoimmunity; steroids

Categories

Funding

  1. Deutsche Forschungsgemeinschaft
  2. Volkswagen Foundation
  3. [AN372/30-1]
  4. [97-744]

Ask authors/readers for more resources

Lupus nephritis is a severe manifestation of systemic lupus erythematosus, and its treatment still faces many challenges. The progression of chronic kidney disease poses risks to patients, while the development of biomarkers provides hope for personalized treatment.
Lupus nephritis is a severe organ manifestation of systemic lupus erythematosus, and its pathogenesis involves complex etiology and mechanisms. Despite significant knowledge gains and extensive efforts put into understanding the development and relapsing disease activity, lupus nephritis remains a substantial cause of morbidity and mortality in lupus patients. Current therapies retain a significant unmet medical need regarding rates of complete response, preventing relapse of lupus nephritis, progression of chronic kidney disease to kidney failure, drug toxicity, and pill burden-related drug non-adherence. Connected to progression of chronic kidney disease are the associated risks for disabling or even lethal cardiovascular events, as well as chronic kidney disease -related secondary immunodeficiency and serious infections. In this regard, biomarkers are needed that can predict treatment response to specific drugs to enable personalized precision medicine. A series of clinical trials with innovative immunomodulatory drugs are ongoing and raise expectations for improvements in the management of lupus nephritis. Here, we review how new developments in pathogenesis connect with current and future perspectives for the management of lupus nephritis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available